Several blood pressure medications have been recalled in recent months and two more have recently been added to the list.
" RELATED: Yet another antihypertensive drug recalled against the risk of cancer
Teva Pharmaceuticals has voluntarily recalled the amlodipine / valsartan and amlodipine / valsartan / hydrochlorothiazide combination tablets, the US Food and Drug Administration announced.
According to the press release, the drugs contain too much N-nitroso-diethylamine (NDEA), a chemical made in Mylan, India. The key ingredient, usually present in certain foods, in drinking water and in air pollution, has been classified as carcinogenic to humans by the International Center for Research on Cancer. Cancer.
" RELATED: Half of US adults now have high blood pressure, according to new guidelines
Teva said she had not received any reports of illness, but had asked her retailers to stop distributing the products and return them immediately.
Patients taking these medications are advised to continue taking the tablets and contact their doctor for advice on other treatments. The company said: "The risk of harm to a patient's health may be higher if treatment is stopped immediately without comparable alternative treatment".
The agency recently recalled three other drugs for the treatment of high blood pressure due to cancer-related concerns, and another was recalled for poor labeling.
Read the full FDA announcement on FDA.gov.